Health Care Equipment & Supplies · NYSE

DHRDanaher Corp

Last close
$233.02 +0.4%
52-week range
$160.93 to $242.80
Market cap
$164B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$24.6B
+3% vs FY24
Net income
$3.61B
-7% vs FY24
Free cash flow
$5.26B
-1% vs FY24
Net cash
-$13.8B
Cash $4.62B, debt $18.4B

Stock price

+198% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on 1 of 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
38.1x
21.3x52.6x
65th percentile, above its median of 35.7x
Price / sales
6.4x
4.3x9.9x
38th percentile, below its median of 7.0x
EV / EBITDA
30.7x
20.0x40.5x
68th percentile, above its median of 29.3x
Price / free cash flow
28.6x
18.6x40.4x
52nd percentile, above its median of 27.8x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-25. Every figure carries its unit.

Valuation

P/E
38.1x
Earnings yield
2.6%
Price / sales
6.4x
Price / book
3.1x
Price / operating cash flow
23.9x
EV / EBITDA
30.7x
EV / sales
7.2x
Free cash flow yield
3.5%

Profitability

Gross margin
58.6%
Operating margin
20.4%
Net margin
16.9%
Return on equity
8.1%
Return on capital
5.8%

Growth per year

Revenue, 3 years
-2.7%
Revenue, 5 years
+2.0%
Revenue, 8 years
+5.9%
EPS, 3 years
-19.4%

Balance sheet

Cash and investments
$5.68B
Total debt
$26.5B
Net cash
-$20.8B
Debt / equity
0.49x
Current ratio
1.63x

Shares and dividend

Shares outstanding
704M
Share count, 5 years
-0.4%
Beta, 1 year
0.53
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
23.5%

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $6.55B
RevenueNet income
Gross profitLatest quarter $3.84B
EBITDALatest quarter $1.45B
Margins59 / 19 / 19%
GrossOperatingNet
Earnings per shareLatest quarter $1.75
Cash flowLatest quarter $1.89B
OperatingCapexFree
Cash vs debtLatest quarter $5.68B
Cash and investmentsTotal debt
P/E historyNow 38.1x
P/E, median 35.7x dashed
P/S historyNow 6.4x
P/S, median 7.0x dashed

Where the revenue comes from

Revenuefrom Contractwith Customer Measurement Nonrecurring went from 22% to 18% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

Revenuefrom Contractwith Customer Measurement RecurringRevenuefrom Contractwith Customer Measurement Nonrecurring
FY22
78%22%
$26.6B
FY23
78%22%
$23.9B
FY24
81%19%
$23.9B
FY25
82%18%
$24.6B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Revenuefrom Contractwith Customer Measurement Recurring$20.1B81.9%+4%
Revenuefrom Contractwith Customer Measurement Nonrecurring$4.44B18.1%-2%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
BSX Boston Scientific Corp $64.3B +9% 18.7%18.8x3.1x 22nd percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Founded
1981
Headquarters
Washington, DC
Fiscal year ends
December
Website
danaher.com

What it does

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about DHR.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 1,795 active funds. Crowd level: quiet.

Open the Smart money tab